The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...

Symbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...

India's plant-based protein ingredient market is set to double to Rs 9,000 crore within five years. Consumers are shifting towards targeted...

Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...

A high-level committee will examine establishing a National Sanjeevani Research Centre for Sea Buckthorn. This initiative aims to position ...

Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...

Shares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...

Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...

For the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

The ethanol story started simply enough: Cut India's dependence on imported crude oil. It would save foreign exchange. Give farmers a new a...

The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...

Bain Capital is nearing a deal to buy a significant stake in IndusInd General Insurance. This acquisition could value the insurer at over s...

With a financial commitment of Rs 3,030 crore, the Union Cabinet has approved the Bhavya Rasayan Scheme. This forward-thinking initiative w...

We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...

In a bid to strengthen consumer protection, India's food regulatory body is intensifying efforts against packaged food companies. The lack ...